Xueqing Wang, Yingxin Lin, Sheng Zhang, Junshi Wang, Bin Huang, Hua Luo, Lei Huang
{"title":"Systemic immune-inflammatory complex index as a novel predictor of sepsis prognosis: a retrospective cohort study using MIMIC-IV.","authors":"Xueqing Wang, Yingxin Lin, Sheng Zhang, Junshi Wang, Bin Huang, Hua Luo, Lei Huang","doi":"10.3389/fmed.2025.1608619","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Sepsis is a life-threatening condition with high mortality and morbidity, making its early detection is critical. Current diagnosis relies on the Sequential [sepsis-related] Organ Failure Assessment score, which is complex and time-consuming to determine. Herein, we proposed a novel index, the systemic immune-inflammatory complex index (SIICI), defined as (neutrophil × monocyte count) × 10<sup>3</sup>/(platelet × lymphocyte count), to predict illness severity, and we verified its prognostic value.</p><p><strong>Methods: </strong>All data were extracted from the Medical Information Mart for Intensive Care database IV (MIMIC-IV). Cox proportional hazards and Kaplan-Meier survival analyses were used to determine the association between target indices and 30- and 90-days mortality. Restricted cubic splines were used to reveal the linear relationship between indices and mortality. To assess the prognostic value of the SIICI, the systemic immune-inflammation index (SII) and systemic inflammation response index (SIRI), the area under the receiver operating characteristic curve (AUC), and the Youden index were measured and compared. Propensity score matching was used to reveal the association between the SIICI and secondary outcomes. Finally, subgroup analysis was performed to confirm the predictive ability of the SIICI.</p><p><strong>Results: </strong>We included 3,944 patients; among these, 609 (15.4%) and 663 (16.8%) patients had 30- and 90-days mortality, respectively. Our findings showed a strong association between the SIICI and mortality at 30 and 90 days in all models, which was more pronounced and better stratified than for the SIRI and SII. The <i>p</i>-value was < 0.05 in all cases; however, the SIICI was closer to a linear relationship with mortality than the SIRI or SII. Additionally, the SIICI had a higher AUC and Youden value than the other two indices. Moreover, a higher SIICI was positively associated with a longer stay in the intensive care unit or the hospital, an increased incidence of acute kidney injury, and greater use of renal replacement therapy and mechanical ventilation.</p><p><strong>Conclusion: </strong>The SIICI was positively associated with sepsis mortality and showed a better prognostic value than the SIRI and SII. The SIICI may be a promising complementary index to classical scoring systems for early assessment of patients with sepsis.</p>","PeriodicalId":12488,"journal":{"name":"Frontiers in Medicine","volume":"12 ","pages":"1608619"},"PeriodicalIF":3.1000,"publicationDate":"2025-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12258050/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fmed.2025.1608619","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose: Sepsis is a life-threatening condition with high mortality and morbidity, making its early detection is critical. Current diagnosis relies on the Sequential [sepsis-related] Organ Failure Assessment score, which is complex and time-consuming to determine. Herein, we proposed a novel index, the systemic immune-inflammatory complex index (SIICI), defined as (neutrophil × monocyte count) × 103/(platelet × lymphocyte count), to predict illness severity, and we verified its prognostic value.
Methods: All data were extracted from the Medical Information Mart for Intensive Care database IV (MIMIC-IV). Cox proportional hazards and Kaplan-Meier survival analyses were used to determine the association between target indices and 30- and 90-days mortality. Restricted cubic splines were used to reveal the linear relationship between indices and mortality. To assess the prognostic value of the SIICI, the systemic immune-inflammation index (SII) and systemic inflammation response index (SIRI), the area under the receiver operating characteristic curve (AUC), and the Youden index were measured and compared. Propensity score matching was used to reveal the association between the SIICI and secondary outcomes. Finally, subgroup analysis was performed to confirm the predictive ability of the SIICI.
Results: We included 3,944 patients; among these, 609 (15.4%) and 663 (16.8%) patients had 30- and 90-days mortality, respectively. Our findings showed a strong association between the SIICI and mortality at 30 and 90 days in all models, which was more pronounced and better stratified than for the SIRI and SII. The p-value was < 0.05 in all cases; however, the SIICI was closer to a linear relationship with mortality than the SIRI or SII. Additionally, the SIICI had a higher AUC and Youden value than the other two indices. Moreover, a higher SIICI was positively associated with a longer stay in the intensive care unit or the hospital, an increased incidence of acute kidney injury, and greater use of renal replacement therapy and mechanical ventilation.
Conclusion: The SIICI was positively associated with sepsis mortality and showed a better prognostic value than the SIRI and SII. The SIICI may be a promising complementary index to classical scoring systems for early assessment of patients with sepsis.
期刊介绍:
Frontiers in Medicine publishes rigorously peer-reviewed research linking basic research to clinical practice and patient care, as well as translating scientific advances into new therapies and diagnostic tools. Led by an outstanding Editorial Board of international experts, this multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide.
In addition to papers that provide a link between basic research and clinical practice, a particular emphasis is given to studies that are directly relevant to patient care. In this spirit, the journal publishes the latest research results and medical knowledge that facilitate the translation of scientific advances into new therapies or diagnostic tools. The full listing of the Specialty Sections represented by Frontiers in Medicine is as listed below. As well as the established medical disciplines, Frontiers in Medicine is launching new sections that together will facilitate
- the use of patient-reported outcomes under real world conditions
- the exploitation of big data and the use of novel information and communication tools in the assessment of new medicines
- the scientific bases for guidelines and decisions from regulatory authorities
- access to medicinal products and medical devices worldwide
- addressing the grand health challenges around the world